LabCorp Lands a Global CRO

In late July, Laboratory Corp. of America Holdings (NYSE: LH) announced the 6th CRO deal to surpass the $1 billion mark this year. The $1.2 billion deal for Chiltern is its third announced transaction this year, having acquired Mount Sinai’s Clinical Outreach Laboratories (January) and Pathology Associates Medical Laboratories, LLC (February).

Sheridan Moves into Phoenix Market

Sheridan just made its fifth announced acquisition of the year, buying Premier Emergency Medical Specialists, a 49-physician group in Phoenix, Arizona. Sheridan is the Physician Services division of AmSurg Corp. (NASDAQ: AMSG), the ambulatory surgery giant, which last year paid $2.35 billion for Sheridan, then a portfolio company of Hellman & Friedman. The purchase marks […]